Oxidative stress is the main stimulative factor for formation and progression of atherosclerosis. Anti-oxidative stress treatment might be the key therapeutic target for patients with ischemic stroke. Probucol is the drug that has relatively strong anti-oxidation effect in clinical practice. Study showed that it could delay the progression of plaque of carotid atherosclerosis of patients with ischemic stroke, and reduce the reoccurrence and mortality of ischemic stroke, which is the hot spot topic in clinical treatment.%氧化应激是动脉粥样硬化形成和发展的重要促进因素,抗氧化应激治疗可能是缺血性卒中患者的重要治疗靶点。普罗布考是临床上具有较强抗氧化应激作用的药物,研究显示,其可以改善缺血性卒中患者颈动脉粥样硬化斑块的发展、降低缺血性卒中的复发率和死亡率,是临床治疗热点之一。
展开▼